Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors

By W. Yeo, P. Chan, S. Zhong, W. Ho, J. Steinberg, J. Tam, P. Hui, N. Leung, B. Zee, Philip J. Johnson. Journal of Medical Virology, 2000

651 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/4f2c2309de6e6be58bcfafc79f620fb8b9af3310

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. RS Brown
2. JB Wong
3. NA Terrault
4. M. Jonas
5. B. McMahon
6. NH Bzowej
7. JP Hwang
8. A. Lok

Citations in the corpus

• Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance (2018, background): “The criteria for HBV reactivation((171-178)) include the following: (1) a rise in HBV DNA compared to baseline (or an absolute level of HBV DNA when a baseline is unavailable) and (2) reverse seroconversion (seroreversion) from HBsAg negative to HBsAg positive for HBsAg-negative and anti-HBc–positiv”